Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 6, pp. 1232-1238
Open Access | Times Cited: 638

Showing 26-50 of 638 citing articles:

COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
Kacper Lechowicz, Sylwester Drożdżal, Filip Machaj, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1917-1917
Open Access | Times Cited: 174
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100719-100719
Open Access | Times Cited: 172
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Kevin Ita
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 15-24
Open Access | Times Cited: 161
Coronavirus disease 2019 (COVID-19) outbreak: some serious consequences with urban and rural water cycle
Gourav Dhar Bhowmick, Dhruba Dhar, Dibyojyoty Nath, et al.
npj Clean Water (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 157
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
Satarudra Prakash Singh, Manisha Pritam, Brijesh Pandey, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 275-299
Open Access | Times Cited: 156
Emerging Technologies for Use in the Study, Diagnosis, and Treatment of Patients with COVID-19
Maria Tsikala Vafea, Eleftheria Atalla, Joanna Georgakas, et al.
Cellular and Molecular Bioengineering (2020) Vol. 13, Iss. 4, pp. 249-257
Open Access | Times Cited: 153
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective
Yashpal Singh Malik, Naveen Kumar, Shubhankar Sircar, et al.
Pathogens (2020) Vol. 9, Iss. 7, pp. 519-519
Open Access | Times Cited: 151
Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, et al.
Clinical Epidemiology and Global Health (2021) Vol. 10, pp. 100694-100694
Open Access | Times Cited: 118
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1539-1550
Open Access | Times Cited: 112
Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine
Marjorie C. Zambonino, Ernesto Mateo Quizhpe, Lynda Mouheb, et al.
Nanomaterials (2023) Vol. 13, Iss. 3, pp. 424-424
Open Access | Times Cited: 74
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 136
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavaraj Shreya, et al.
Life Sciences (2020) Vol. 256, pp. 117883-117883
Open Access | Times Cited: 131
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
Ranjan K. Mohapatra, Lucia Pintilie, Venkataramana Kandi, et al.
Chemical Biology & Drug Design (2020) Vol. 96, Iss. 5, pp. 1187-1208
Open Access | Times Cited: 128
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
Anwar M. Hashem, Badrah S. Alghamdi, Abdullah Algaissi, et al.
Travel Medicine and Infectious Disease (2020) Vol. 35, pp. 101735-101735
Open Access | Times Cited: 127
Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19
Aditi Banerjee, Steven J. Czinn, Rüssel J. Reiter, et al.
Life Sciences (2020) Vol. 255, pp. 117842-117842
Open Access | Times Cited: 118
Dengue Fever, COVID‐19 (SARS‐CoV‐2), and Antibody‐Dependent Enhancement (ADE): A Perspective
Henning Ulrich, Micheli Mainardi Pillat, Attila Tárnok
Cytometry Part A (2020) Vol. 97, Iss. 7, pp. 662-667
Open Access | Times Cited: 113
SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences
Melika Lotfi, Nima Rezaei
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 1864-1874
Open Access | Times Cited: 110
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
Rajat Mudgal, Sanketkumar Nehul, Shailly Tomar
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2921-2931
Open Access | Times Cited: 108
Micronutrients as immunomodulatory tools for COVID-19 management
Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, et al.
Clinical Immunology (2020) Vol. 220, pp. 108545-108545
Open Access | Times Cited: 104
Recombinant vaccines for COVID-19
Tushar Yadav, Nishant Srivastava, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2905-2912
Open Access | Times Cited: 103
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
Igor Andrade Santos, Victória Riquena Grosche, Fernando R.G. Bergamini, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 101
Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods
O. S. Albahri, Jameel R. Al‐Obaidi, A. A. Zaidan, et al.
Computer Methods and Programs in Biomedicine (2020) Vol. 196, pp. 105617-105617
Open Access | Times Cited: 96
Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond
Kuldeep Dhama, Shailesh Kumar Patel, Rakesh Kumar, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 94
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2
Vijaya Anand Arumugam, Balamuralikrishnan Balasubramanian, Mohandass Kaviya, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1775-1775
Open Access | Times Cited: 93
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, John P. Moore
eLife (2020) Vol. 9
Open Access | Times Cited: 92

Scroll to top